| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |